News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports Michael O'Riordan December 21, 2021
News Daily News Studies Zero in on Delayed Conduction Problems After TAVI Todd Neale December 21, 2021
News Daily News For Angina Patients, Language Barriers Can Complicate CVD Care Caitlin E. Cox December 20, 2021
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Daily News More Than One in 10 UK Cardiology Trainees Report Being Bullied Yael L. Maxwell December 07, 2021
News Daily News INTERSTROKE: Anger, Heavy Physical Exertion May Trigger Strokes Todd Neale December 02, 2021
News Daily News Best Exercise for Heart Health? Some Hints of Intensity’s Role Michael O'Riordan December 02, 2021
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News AHA 2021 Dietary Patterns, Social Pressures: AHA Offers New Nutrition Advice Caitlin E. Cox November 19, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021